Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04208958
Title Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer (Consortium-IO)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Vedanta Biosciences, Inc.

Advanced Solid Tumor


Nivolumab + Vancomycin + VE800

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.